Oversight of the new drug review process and FDA's regulation of Merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986.

Oversight of the new drug review process and FDA's regulation of Merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986.

Saved in:

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (Author)
Format:	Electronic eBook
Language:	English
Published:	Washington : U.S. Government Printing Office, 1987.
Series:	U.S. Congressional documents. Congressional hearings.
Subjects:	United States. > Food and Drug Administration. Drugs > Law and legislation > United States. Pharmacy > Law and legislation > United States. Nomifensine. Electronic books.
Online Access:	HeinOnline U.S. Congressional Documents Collection
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Oversight of the new drug review process and FDA's regulation of Merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986
Published: (1987)

FDA's authority to regulate drug compounding : a legal analysis /
by: Staman, Jennifer A.
Published: (2012)

The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982.
Published: (1982)

The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982
Published: (1982)

Drug regulation reform--oversight. hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session, on food and drug administration regulation of research, development, and marketing of drugs, June 25, 1980.
Published: (1980)

Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress ..
Published: (1980)

Drug regulation reform--oversight. hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress on how can we best use our limited resources and at the same time insure safe and effective drugs to diseases which occur infrequently.
Published: (1980)

The regulation of pharmaceuticals : balancing the benefits and risks /
by: Grabowski, Henry G
Published: (1983)

Drug safety amendments of 1976 : hearings before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, second session, on H.R. 11617 and H.R. 12391, bills to amend the Federal food, drug, and cosmetic act, March 29 and 30, April 1, 1976, and H.R. 14289, a bill to amend the federal food, drug, and cosmetic act and related provisions of law to improve the protection of the public health and safety with respect to drugs, June 22, 23, and 24, 1976.
Published: (1976)

Preclinical and clinical testing by the pharmaceutical industry, 1978. hearing before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, second session on examination of the process of drug testing and FDA' role in the regulation and conditions under which such testing is carried out, March 7, 1978.
Published: (1978)

Preclinical and clinical testing by the pharmaceutical industry, 1977. hearing before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, first session on examination of the process of drug testing and FDA' role in the regulation and conditions under which such testing is carried out, March 10, 1977.
Published: (1977)

FDA's regulation of the new drug Suprol : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, May 27, 1987.
Published: (1988)

FDA's regulation of the new drug Suprol : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, May 27, 1987
Published: (1988)

The law of drugs and druggists : a treatise with text, cases, statutes, readings, and digests for schools of pharmacy, retail, wholesale, and manufacturing druggists /
by: Arthur, William Reed, 1876-
Published: (1947)

FDA's regulation of the new drug Versed : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988.
Published: (1988)

FDA's regulation of the new drug Versed : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988
Published: (1988)

Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session on H.R. 2454, a bill to authorize the Secretary of Health and Human Services to impose debarments and other penalties for illegal activities involving the approval of abbreviated drug applications under the Federal Food, Drug, and Cosmetic Act, June 26, 1991.
Published: (1991)

The regulation of pharmaceuticals : balancing the benefits and risks /
by: Grabowski, Henry G., et al.
Published: (1983)

How FDA approves drugs and regulates their safety and effectiveness /
by: Bodie, Agata, et al.
Published: (2018)

How FDA approves drugs and regulates their safety and effectiveness /
by: Thaul, Susan
Published: (2012)

How FDA approves drugs and regulates their safety and effectiveness /
by: Thaul, Susan
Published: (2012)

How FDA approves drugs and regulates their safety and effectiveness.
Published: (2013)

FDA regulation of the new drug "Serc". Hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, second session.
Published: (1972)

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

Drug regulation reform act of 1978 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, second session on S. 2755
Published: (1978)

Drug Regulation Reform Act of 1978. hearings before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session on H.R. 11611 (and all other similar and identical bills), bills to revise and reform the federal law applicable to drugs for human use and to establish a National Center for Clinical Pharmacology within the Department of Health, Education, and Welfare, and for other purposes, June 6, 12, 13, 14, 15, 19, 20, 21, 22, 23, and 27, 1978.
Published: (1979)

Drug Regulation Reform Act of 1978. hearings before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session on H.R. 11611 (and all other similar and identical bills), bills to revise and reform the federal law applicable to drugs for human use and to establish a National Center for Clinical Pharmacology within the Department of Health, Education, and Welfare, and for other purposes, June 6, 12, 13, 14, 15, 19, 20, 21, 22, 23, and 27, 1978.
Published: (1978)

Drug Regulation Reform Act of 1979 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, first session on S. 1075, to revise and reform federal law applicable to drugs for human use, and for other purposes and related bills, May 17 and 18, 1979.
Published: (1979)

Drug regulation reform act of 1979 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, first session, on S. 1075 ... May 17 and 18, 1979
Published: (1979)

Drug regulation reform act of 1978 : hearings before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, on H.R. 11611 (and all other similar and identical bills)
Published: (1978)

Selected resources on federal oversight of compounding pharmacies.
Published: (2013)

Drug Regulation Reform Act of 1978 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, second session on S. 2755, to revise and reform the federal law applicable to drugs for human use and to establish a National Center for Clinical Pharmacology within the Department of Health, Education, and Welfare, March 17; April 11, 12; and May 17, 1978, Washington, D.C., May 18, 1978, Rockville, Md.
Published: (1978)

Food and Drug Administration (FDA) : overview and issues /
by: Williams, Erin D.
Published: (2008)

FDA regulation of the new drug "Serc" : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, second session. September 25, 1972.
Published: (1972)

FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992.
Published: (1992)

FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992
Published: (1992)

Key issues in pharmaceuticals law /
Published: (2007)

Substitute Prescription Drug Act : hearings before the Subcommittee on Consumer Protection and Finance of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, on H.R. 1963, a bill to permit pharmacists, in certain circumstances, to use substitute drugs in the filling or refilling of prescriptions made by physicians, June 22 and July 27, 1978.
Published: (1978)

Food, Drug, and Cosmetic Act Amendments of 1977 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, first session on S. 1831, to amend the Public Health Services Act to provide for a national center for clinical pharmacology, to provide support for the study of clinical pharmacology and clinical pharmacy, and to provide for review of, drug prescribing; and to amend the Federal Food, Drug, and Cosmetic Act, as amended, to provide for the continuation and expansion of existing authority through the establishment of an appropriate mechanism to be known as the Federal Food, Drug, Cosmetic, and Devices Administration; to provide for additional regulation of the pharmaceutical industry, and for other purposes and related bills, July 26 and 27, 1977.
Published: (1978)

Modernizing FDA's regulation of over-the-counter drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. September 13, 2017
Published: (2018)